Jeak Ling DING
Professor

Address:
Department of Biological Sciences, 14 Science Drive 4, National University of Singapore, Kent Ridge,
Singapore 117543

Tel: (65) 6516-2776; Fax: (65) 6779-2486;
Email: dbsdjl@nus.edu.sg;
URL: http://www.dbs.nus.edu.sg/Staff/ding.html

Qualifications:
BSc Hons - Biochemistry (University of Wales, UK) - 1978
PhD - Biochemistry (University of London, UK) - 1982

 

Field of Research: Innate immunity - pathogen surveillance strategies

Molecular Biology of 'host-pathogen interaction' and innate immunity - functional genomics and protein-protein interaction studies of innate immune molecules and microbial PAMPs during infection, and characterization of LPS-binding proteins and peptides. Development of novel biosensors for LPS; new strategies for removal of LPS from pharmaceutical products; novel antimicrobial peptides.

 

Employment Record:
1982:   Postdoc. Res. Fellow, MRC Clinical Res. Centre, London, UK.
1982-84:  Research Scientist, Dept. Medicine, Natl. Univ. of S'pore (NUS)
1984-85:  Teaching Fellow, Dept. of Zoology, NUS
1985-88:  Lecturer, Dept. of Zoology, NUS
1989-94:  Senior Lecturer, Dept. of Zoology, NUS
1995- 2001:  Assoc. Prof., Dept. of Biological Sciences, NUS
2001- :  Professor, Dept. Biological Sciences, NUS

 

Scholarships & Awards:
1978: British Empire Cancer Research Campaign Scholarship
1991: Whitehead Award for Best Scientific Contribution to Clinical Biochemistry, Singapore.
1994: Award for Outstanding Lecturer in 'Cell & Molecular Biology', NUS
1995: Natl Sci. & Technol Award, Singapore (Outstanding Contribution to Genetic Engnr)
2000: Far Eastern Economic Review (FEER) Innovations Award
2001: National University of Singapore 'Outstanding Researcher Award'

2008: NUS FoS 'Outstanding Scientist Award'

2009: Provost Chair Professorship

 

Publications & Patents:
Publications: >200 (International Refereed Journals; Conference Papers; Chapters in Books & Monographs) Patents: 15 Granted & 2 Filed (US, PCT)

 

Commercialisation of Intellectual Properties:

• Licensing of genetically-engineered limulus Factor C (as diagnostic for bacterial endotoxin) to US Biotech Co.
• Ongoing commercial evaluation of:
  - novel cloning vector for molecular biology & biotechnology
  - peptide antibiotics
  - High performance affinity purification / removal of endotoxin